tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market
Advertisement

KalVista Pharmaceuticals (KALV) Stock Investors

Compare
573 Followers
Based on 830,602 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold KALV
On average, investors allocate 2.32% of their portfolios to KALV
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 830,602 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding KALV

6.2%
Last 7
Days
7.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding KALV, out of 830,602 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

KALV Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$14.76
Increased
1.35%
$11.41
Opened
<0.01%
$13.38
Reduced
9.09%
$14.86
Reduced
0.73%
$11.82
Based on the activity of investors who made their portfolios public
The table shows changes in KALV in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

KALV Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Abbott Laboratories
2.43%
+0.25%
+0.29%
217.50B
Healthcare
Riot Platforms
4.29%
+0.69%
+5.91%
5.55B
Financial
Delta Air Lines
4.06%
+0.13%
+0.28%
43.81B
Industrials
MARA Holdings
3.94%
+0.38%
+0.54%
4.44B
Financial
JD
3.21%
+0.38%
+0.99%
43.64B
Consumer Cyclical
Block
2.68%
+1.20%
+0.02%
37.13B
Technology
Crispr Therapeutics AG
3.10%
+0.13%
+2.20%
5.42B
Healthcare
Nio
4.72%
+0.41%
+1.08%
10.81B
Consumer Cyclical
Cleanspark
4.13%
+2.06%
+8.13%
3.51B
Financial
Viking Therapeutics
3.74%
-0.59%
+0.64%
4.36B
Healthcare
Based on the activity of 830,602 active portfolios
Open your Smart Portfolio

KALV Investor Analysis

KALV investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.2%
of KALV holders
are under 35
Average Segment Performance
Average P/E Ratio42.78
Beta-3.59
Dividend Yield4.75%
KALV investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.1%
of KALV holders
are between 35–55
Average Segment Performance
Average P/E Ratio37.76
Beta5.19
Dividend Yield4.77%
KALV investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
32.7%
of KALV holders
are over 55
Average Segment Performance
Average P/E Ratio36.44
Beta0.84
Dividend Yield3.56%
Overview of age group and performance of KALV stock investors
See who invests in KALV according to age group and performance.

FAQ

How many retail Investors hold KALV?
<0.1% of TipRanks' retail investors hold KALV in their portfolios.
    What is KALV Investor Sentiment?
    KALV’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of KALV in the last 7 days?
      ▼ 6.2% of TipRanks' retail investors changed their holding of KALV in the last 7 days.
        What percentage of retail investors changed their holding of KALV in the last 30 days?
        ▼ 7.5% of TipRanks' retail investors changed their holding of KALV in the last 30 days.
          What is the average age of retail investors who hold KALV?
          The average age of KALV Holders is between 35–55.
            What other stocks have KALV investors also bought?
            KALV Investors also bought ABT, RIOT, DAL, MARA, JD, XYZ, CRSP, NIO, CLSK, VKTX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis